These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2573498)

  • 41. Metabolic fate of the novel antihypertensive drug naftopidil.
    Niebch G; Locher M; Peter G; Borbe HO
    Arzneimittelforschung; 1991 Oct; 41(10):1027-32. PubMed ID: 1665973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
    Balani SK; Woolf EJ; Hoagland VL; Sturgill MG; Deutsch PJ; Yeh KC; Lin JH
    Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat.
    Koble DL; Koons JC; Fischer LJ
    Drug Metab Dispos; 1985; 13(3):305-11. PubMed ID: 2861988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reductive isoxazole ring opening of the anticoagulant razaxaban is the major metabolic clearance pathway in rats and dogs.
    Zhang D; Raghavan N; Chen SY; Zhang H; Quan M; Lecureux L; Patrone LM; Lam PY; Bonacorsi SJ; Knabb RM; Skiles GL; He K
    Drug Metab Dispos; 2008 Feb; 36(2):303-15. PubMed ID: 17984286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats.
    Johnson KA; Prakash C
    Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elimination pathways of terbutaline.
    Tegnér K; Nilsson HT; Persson CG; Persson K; Ryrfeldt A
    Eur J Respir Dis Suppl; 1984; 134():93-100. PubMed ID: 6586491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biotransformation of an alpha4beta2 nicotinic acetylcholine receptor partial agonist in sprague-dawley rats and the dispositional characterization of its N-carbamoyl glucuronide metabolite.
    Shaffer CL; Ryder TF; Venkatakrishnan K; Henne IK; O'Connell TN
    Drug Metab Dispos; 2009 Jul; 37(7):1480-9. PubMed ID: 19339375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
    Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.
    Cayen MN; Hicks DR; Ferdinandi ES; Kraml M; Greselin E; Dvornik D
    Drug Metab Dispos; 1985; 13(4):412-9. PubMed ID: 2863103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of sodium salicylate on elimination kinetics of indomethacin and bile production in dogs.
    Beck WS; Dietzel K; Geisslinger G; Engler H; Vergin H; Brune K
    Drug Metab Dispos; 1990; 18(6):962-7. PubMed ID: 1981545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic administration of sertraline, a selective serotonin uptake inhibitor, decreased the density of beta-adrenergic receptors in rat frontoparietal cortex.
    Byerley WF; McConnell EJ; McCabe RT; Dawson TM; Grosser BI; Wamsley JK
    Brain Res; 1987 Sep; 421(1-2):377-81. PubMed ID: 2825912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dose-dependent toxicokinetics of L-689,502, a potent human immunodeficiency virus protease inhibitor, in rats and dogs.
    Lin JH; Chen IW; King J
    J Pharmacol Exp Ther; 1992 Oct; 263(1):105-11. PubMed ID: 1403775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sertraline and cocaine-induced locomotion in mice. I. Acute studies.
    Reith ME; Wiener HL; Fischette CT
    Psychopharmacology (Berl); 1991; 103(3):297-305. PubMed ID: 2057535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The metabolism of 2,4-dibromo-17 alpha-ethynyl[6,7-3H]oestradiol in the rat.
    Maggs JL; Morgan P; Hussain F; Page PC; Park BK
    Xenobiotica; 1990 Jan; 20(1):45-54. PubMed ID: 2327107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration. I. Disposition and metabolic profiling.
    Gerding TK; Drenth BF; Roosenstein HJ; de Zeeuw RA; Tepper PG; Horn AS
    Xenobiotica; 1990 May; 20(5):515-24. PubMed ID: 1971983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotonin uptake inhibition: in vivo effect of sertraline in rats.
    Manfridi A; Clavenna A; De Simoni MG
    Neurosci Lett; 1992 May; 139(1):69-72. PubMed ID: 1383885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lamotrigine toxicity secondary to sertraline.
    Kaufman KR; Gerner R
    Seizure; 1998 Apr; 7(2):163-5. PubMed ID: 9627209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The metabolism of ondansetron.
    Saynor DA; Dixon CM
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S75-7. PubMed ID: 2533904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distribution and excretion of sertraline and N-desmethylsertraline in human milk.
    Kristensen JH; Ilett KF; Dusci LJ; Hackett LP; Yapp P; Wojnar-Horton RE; Roberts MJ; Paech M
    Br J Clin Pharmacol; 1998 May; 45(5):453-7. PubMed ID: 9643617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.